First Circuit affirms $142 million verdict against Pfizer in three Neurontin cases.
By: chris.placitella @ Apr 05, 2013
The First Circuit Court of Appeals changed the landscape for third-party payor cases involving defective pharmaceuticals. The opinions are important in terms of how plaintiffs go about proving their cases from a causation and damages perspective. The First Circuit yesterday materially softened the individual proof rule and is willing to allow in aggregate proof in […]
Brought to you by: